Wittouck Amaury insider trades
Wittouck Amaury has filed 5 Form 4s with the SEC that we hold, for Crescent Biopharma, INC. (GLYC) (10% owner), Cava Group, INC. (CAVA) (Director, 10% owner) and Scholar Rock Holding Corp (SRRK) (10% owner). Across all of them we count 7 purchases worth $18.3M and 1 sale worth $132.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 2,000,000 shares of Cava Group, INC. worth $132.5M, dated 2024-03-21. The first filing on our record is dated 2023-02-13 and the latest 2024-03-25.
Crescent Biopharma, INC. (GLYC)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-02-09 | P, purchase reported on Form 4 | 11,451 | $37.1K | 2023-02-13 |
| 2023-02-15 | P, purchase reported on Form 4 | 1,000,000 | $2.2M | 2023-02-17 |
| 2023-02-16 | P, purchase reported on Form 4 | 315,266 | $529.6K | 2023-02-17 |
| 2023-02-17 | P, purchase reported on Form 4 | 200,000 | $342.0K | 2023-02-17 |
| 2023-02-24 | P, purchase reported on Form 4 | 100,000 | $170.0K | 2023-02-28 |
Cava Group, INC. (CAVA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-21 | S, sale reported on Form 4 | 2,000,000 | $132.5M | 2024-03-25 |
Scholar Rock Holding Corp (SRRK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-10-12 | P, purchase reported on Form 4 | 2,189,781 | $15.0M | 2023-10-16 |
| 2023-10-12 | P, purchase reported on Form 4 | 10,150 | $86.8K | 2023-10-16 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1841311) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms